“Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s178. doi:10.25251/skin.7.supp.178.